Medunik USA announces two savings programs that allow families affected by sickle cell disease to pay as little as $0 for their child’s Siklos® prescription

Read more

Siklos®, the first and only hydroxyurea-based treatment for pediatric patients with sickle cell anemia, now available in 1,000 mg triple-scored tablets to help optimize dosing

Read more

Siklos® (hydroxyurea) now available through ProCare Pharmacy Care’s Siklos At Home™ program

Read more

Siklos®, the first and only hydroxyurea-based treatment for pediatric patients with sickle cell anemia, now available in retail pharmacies

Read more